{
    "2018-03-12": [
        [
            {
                "time": "",
                "original_text": "医疗保健：好公司值得长期拥有 荐8股",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "好公司",
                        "长期拥有"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗保健"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医疗保健：主营业务可持续增长更具长期投资价值 荐12股",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "主营业务",
                        "可持续增长",
                        "长期投资价值"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗保健"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[推荐评级]医药行业周报：把握流通板块投资机会 关注低估值优质企业",
                "features": {
                    "keywords": [
                        "医药行业",
                        "流通板块",
                        "投资机会",
                        "低估值",
                        "优质企业"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物又一年净利润5亿元以上 的疫苗4月上旬前获准销售",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "净利润",
                        "疫苗",
                        "4月上旬",
                        "获准销售"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医改联动药企创新加速 五股有望率先发力",
                "features": {
                    "keywords": [
                        "医改",
                        "药企创新",
                        "五股",
                        "率先发力"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医改联动药企创新加速 近9亿元大单抢筹9只医药股",
                "features": {
                    "keywords": [
                        "医改",
                        "药企创新",
                        "大单",
                        "医药股"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}